Stay updated on GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Sign up to get notified when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.

Latest updates to the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page
- ChecktodayChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new release of the page. No substantive content changes are indicated by this update.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe sponsor on the study record changed from Galapagos NV to Lakefront Biotherapeutics NV, updating the record to reflect the current sponsor responsible for the trial.SummaryDifference0.2%

- Check22 days agoChange DetectedThe revision tag in the page footer was updated from v3.5.3 to v3.5.4, signaling a minor version update of the platform. This change does not modify the displayed study information or navigation.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page’s footer/site build has been updated from Revision v3.5.2 to v3.5.3, reflecting a website release rather than any change to the clinical trial information.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2. This appears to be a metadata update rather than a substantive change to the study content.SummaryDifference0.0%

- Check79 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.